GAO Reviewing 340B Contract Pharmacy Arrangements
The U.S. Government and Accountability Office (GAO) is examining 340B contract pharmacy arrangements, although we do not yet know the purpose of the GAO’s review. The GAO is the investigative…
Fighting to Preserve the Benefits of the 340B Program
The U.S. Government and Accountability Office (GAO) is examining 340B contract pharmacy arrangements, although we do not yet know the purpose of the GAO’s review. The GAO is the investigative…
Several manufacturers of leading antiretroviral drugs increased wholesale acquisition cost (WAC) prices at the beginning of this year, despite an open letter submitted by the Fair Pricing Coalition and more…